These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 26829184)

  • 1. Effect of long chain omega-3 polyunsaturated fatty acids on inflammation and metabolic markers in hypertensive and/or diabetic obese adults: a randomized controlled trial.
    Ellulu MS; Khaza'ai H; Patimah I; Rahmat A; Abed Y
    Food Nutr Res; 2016; 60():29268. PubMed ID: 26829184
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of vitamin C on inflammation and metabolic markers in hypertensive and/or diabetic obese adults: a randomized controlled trial.
    Ellulu MS; Rahmat A; Patimah I; Khaza'ai H; Abed Y
    Drug Des Devel Ther; 2015; 9():3405-12. PubMed ID: 26170625
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dried blood spot omega-3 and omega-6 long chain polyunsaturated fatty acid levels in 7-9 year old Zimbabwean children: a cross sectional study.
    Mashavave G; Kuona P; Tinago W; Stray-Pedersen B; Munjoma M; Musarurwa C
    BMC Clin Pathol; 2016; 16():14. PubMed ID: 27499701
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A high ratio of dietary n-3/n-6 polyunsaturated fatty acids improves obesity-linked inflammation and insulin resistance through suppressing activation of TLR4 in SD rats.
    Liu HQ; Qiu Y; Mu Y; Zhang XJ; Liu L; Hou XH; Zhang L; Xu XN; Ji AL; Cao R; Yang RH; Wang F
    Nutr Res; 2013 Oct; 33(10):849-58. PubMed ID: 24074743
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Eicosapentaenoic Acid Versus Docosahexaenoic Acid as Options for Vascular Risk Prevention: A Fish Story.
    Singh S; Arora RR; Singh M; Khosla S
    Am J Ther; 2016; 23(3):e905-10. PubMed ID: 25828517
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of eicosapentaenoic acid and docosahexaenoic acid on oxidative stress and inflammatory markers in treated-hypertensive type 2 diabetic subjects.
    Mori TA; Woodman RJ; Burke V; Puddey IB; Croft KD; Beilin LJ
    Free Radic Biol Med; 2003 Oct; 35(7):772-81. PubMed ID: 14583341
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Influence of Human Milk and Parenteral Lipid Emulsions on Serum Fatty Acid Profiles in Extremely Preterm Infants.
    Nilsson AK; Löfqvist C; Najm S; Hellgren G; Sävman K; Andersson MX; Smith LEH; Hellström A
    JPEN J Parenter Enteral Nutr; 2019 Jan; 43(1):152-161. PubMed ID: 29679529
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-chain n-3 PUFAs reduce adipose tissue and systemic inflammation in severely obese nondiabetic patients: a randomized controlled trial.
    Itariu BK; Zeyda M; Hochbrugger EE; Neuhofer A; Prager G; Schindler K; Bohdjalian A; Mascher D; Vangala S; Schranz M; Krebs M; Bischof MG; Stulnig TM
    Am J Clin Nutr; 2012 Nov; 96(5):1137-49. PubMed ID: 23034965
    [TBL] [Abstract][Full Text] [Related]  

  • 9. n-3 Polyunsaturated fatty acids for the management of alcoholic liver disease: A critical review.
    Wang M; Ma LJ; Yang Y; Xiao Z; Wan JB
    Crit Rev Food Sci Nutr; 2019; 59(sup1):S116-S129. PubMed ID: 30580553
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lipid-lowering and anti-inflammatory effects of omega 3 ethyl esters and krill oil: a randomized, cross-over, clinical trial.
    Cicero AF; Rosticci M; Morbini M; Cagnati M; Grandi E; Parini A; Borghi C
    Arch Med Sci; 2016 Jun; 12(3):507-12. PubMed ID: 27279841
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Omega-3 polyunsaturated fatty acids in treating non-alcoholic steatohepatitis: A randomized, double-blind, placebo-controlled trial.
    Nogueira MA; Oliveira CP; Ferreira Alves VA; Stefano JT; Rodrigues LS; Torrinhas RS; Cogliati B; Barbeiro H; Carrilho FJ; Waitzberg DL
    Clin Nutr; 2016 Jun; 35(3):578-86. PubMed ID: 26047766
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Similar eicosapentaenoic acid and docosahexaenoic acid plasma levels achieved with fish oil or krill oil in a randomized double-blind four-week bioavailability study.
    Yurko-Mauro K; Kralovec J; Bailey-Hall E; Smeberg V; Stark JG; Salem N
    Lipids Health Dis; 2015 Sep; 14():99. PubMed ID: 26328782
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of N-3 PUFAs supplementation on insulin resistance and inflammatory biomarkers in hemodialysis patients.
    Rasic-Milutinovic Z; Perunicic G; Pljesa S; Gluvic Z; Sobajic S; Djuric I; Ristic D
    Ren Fail; 2007; 29(3):321-9. PubMed ID: 17497447
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anti-inflammatory effects of omega 3 and omega 6 polyunsaturated fatty acids in cardiovascular disease and metabolic syndrome.
    Tortosa-Caparrós E; Navas-Carrillo D; Marín F; Orenes-Piñero E
    Crit Rev Food Sci Nutr; 2017 Nov; 57(16):3421-3429. PubMed ID: 26745681
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The impact of non-surgical periodontal treatment on serum levels of long chain-polyunsaturated fatty acids: a pilot randomized clinical trial.
    Martinez GL; Koury JC; Brito F; Fischer RG; Gustafsson A; Figueredo CM
    J Periodontal Res; 2014 Apr; 49(2):268-74. PubMed ID: 23721647
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Omega-3 PUFAs improved endothelial function and arterial stiffness with a parallel antiinflammatory effect in adults with metabolic syndrome.
    Tousoulis D; Plastiras A; Siasos G; Oikonomou E; Verveniotis A; Kokkou E; Maniatis K; Gouliopoulos N; Miliou A; Paraskevopoulos T; Stefanadis C
    Atherosclerosis; 2014 Jan; 232(1):10-6. PubMed ID: 24401211
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Omega-3 polyunsaturated fatty acids in the treatment of hypertriglyceridaemia.
    Pirillo A; Catapano AL
    Int J Cardiol; 2013 Dec; 170(2 Suppl 1):S16-20. PubMed ID: 23856442
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cytokine distribution in mothers and breastfed children after omega-3 LCPUFAs supplementation during the last trimester of pregnancy and the lactation period: A randomized, controlled trial.
    Rodriguez-Santana Y; Ochoa JJ; Lara-Villoslada F; Kajarabille N; Saavedra-Santana P; Hurtado JA; Peña M; Diaz-Castro J; Sebastian-Garcia I; Machin-Martin E; Villanueva M; Ramirez-Garcia O; Peña-Quintana L
    Prostaglandins Leukot Essent Fatty Acids; 2017 Nov; 126():32-38. PubMed ID: 29031393
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Potential therapeutic impact of omega-3 long chain-polyunsaturated fatty acids on inflammation markers in Duchenne muscular dystrophy: A double-blind, controlled randomized trial.
    Rodríguez-Cruz M; Cruz-Guzmán ODR; Almeida-Becerril T; Solís-Serna AD; Atilano-Miguel S; Sánchez-González JR; Barbosa-Cortés L; Ruíz-Cruz ED; Huicochea JC; Cárdenas-Conejo A; Escobar-Cedillo RE; Yam-Ontiveros CA; Ricárdez-Marcial EF
    Clin Nutr; 2018 Dec; 37(6 Pt A):1840-1851. PubMed ID: 28987470
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A novel, multi-ingredient supplement to manage elevated blood lipids in patients with no evidence of cardiovascular disease: a pilot study.
    Hobbs T; Caso R; McMahon D; Nymark M
    Altern Ther Health Med; 2014; 20(5):18-23. PubMed ID: 25141367
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.